研究実績  |  RESULTS ACHIEVEMENT

英文論文

    2019
  • Oikawa Y, Sakamoto K, Satomura A, Haisa A, Katsuki T, Hattori Y, Inoue I, Noda M, Shimada A. Significance of peripheral mononuclear cells producing interferon-γ in response to insulin B:9–23-related peptides in subtypes of type 1 diabetes. Clin Immunol. 2019 (In press)

  • 2019
  • Satomura A, Oikawa Y, Haisa A, Inoue I, Noda M, Shimada A. Body weight threshold for sudden onset of ketosis may exist in ketosis-prone type 2 diabetes. J Diabetes Investig. 2019 (In press)

  • 2019
  • Hatano M, Mimura T, Shimada A, Noda M, Katayama S. Hepatitis B virus reactivation with corticosteroid therapy in patients with adrenal insufficiency. Endocrinology, Diabetes & Metabolism. 2019 May 9;2(3):e00071.

  • 2019
  • Nakamura Y, Nagai Y, Kobayashi T, Furukawa K, Oikawa Y, Shimada A, Tanaka Y. Characteristics of Gut Microbiota in Patients With Diabetes Determined by Data Mining Analysis of Terminal Restriction Fragment Length Polymorphisms. J Clin Med Res. 2019 Jun;11(6):401-406

  • 2019
  • Katanoda K, Noda M, Goto A, Mizunuma H, Lee JS, Hayashi K. Being underweight in adolescence is independently associated with adult-onset diabetes among women: The Japan Nurses’ Health Study. J Diabetes Investig. 2019 May;10(3):827-836.

  • 2019
  • Nakashima N, Noda M, Ueki K, Koga T, Hayashi M, Yamazaki K, Nakagami T, Ohara M, Gochi A, Matsumura Y, Kimura M, Ohe K, Kang D, Toya Y, Yamagata K, Yokote K, Ikeda S, Mitsutake N, Yamamoto R, Tanizawa Y. Recommended configuration for personal health records by standardized data item sets for diabetes mellitus and associated chronic diseases: A report from Collaborative Initiative by six Japanese Associations. J Diabetes Investig. 2019 May;10(3):868-875. 

  • 2019
  • Goto A, Yamaji T, Sawada N, Momozawa Y, Kamatani Y, Kubo M, Shimazu T, Inoue M, Noda M, Tsugane S, Iwasaki M. Diabetes and cancer risk: A Mendelian randomization study. Int J Cancer. 2019 (In press)

  • 2019
  • Oikawa Y, Kondo T, Shimada A, Seino Y, Kitaoka M: Actual condition survey regarding mismatch of measurements between radioimmunoassay and enzyme-linked immunosorbent assay tests for anti-glutamic acid decarboxylase antibody in real-world clinical practice. J Diabetes Investig. 2019 May;10(3):685-689.

  • 2019
  • Saito D, Oikawa Y, Yano Y, Ikegami Y, Satomura A, Isshiki M, Kurihara S, Inoue I, Noda M, Shimada A. Detailed Time Course of Decline in Serum C-Peptide Levels in Anti-Programmed Cell Death-1 Therapy-Induced Fulminant Type 1 Diabetes. Diabetes Care. 2019 Mar;42(3):e40-e41.

  • 2019
  • Saito D, Oikawa Y, Mizutani G, Inoue K, Hatano M, Inoue I, Noda M, Shimada A. Clinical characteristics of anti-glutamic acid decarboxylase antibody-positive fulminant type 1 diabetes. Endocr J. 2019 Apr 25;66(4):329-336.

  • 2019
  • Nakano T, Inoue I, Murakoshi T. A Newly Integrated Model for Intestinal Cholesterol Absorption and Efflux Reappraises How Plant Sterol Intake Reduces Circulating Cholesterol Levels. Nutrients. 2019 Feb 1;11(2). pii: E310.

  • 2019
  • Yasuda S, Iuchi T, Goto A, Katanoda K, Iida S, Oikawa Y, Namba A, Isshiki M, Inoue I, Kamei Y, Shimada A, Noda M. Weight control before and during pregnancy for patients with gestational diabetes mellitus. J Diabetes Investig. 2019 Jul;10(4):1075-1082.

  • 2019
  • Hidaka A, Budhathoki S, Yamaji T, Sawada N, Tanaka-Mizuno S, Kuchiba A, Charvat H, Goto A, Shimazu T, Inoue M, Noda M, Tsugane S, Iwasaki M; JPHC Study Group. Plasma C-peptide and glycated albumin and subsequent risk of cancer: From a large prospective case-cohort study in Japan. Int J Cancer. 2019 Feb 15;144(4):718-729.

  • 2019
  • Nanri A, Mizoue T, Noda M, Goto A, Sawada N, Tsugane S; Japan Public Health Center-based Prospective Study (JPHC Study) Group. Menstrual and reproductive factors and type 2 diabetes risk: The Japan Public Health Center-based Prospective Study. J Diabetes Investig. 2019 Jan;10(1):147-153.

  • 2019
  • Kawabata Y, Nishida N, Awata T, Kawasaki E, Imagawa A, Shimada A, Osawa H, Tanaka S, Takahashi K, Nagata M, Yasuda H, Uchigata Y, Kajio H, Makino H, Yasuda K, Kobayashi T, Hanafusa T, Tokunaga K, Ikegami H. Genome-Wide Association Study Confirming a Strong Effect of HLA and Identifying Variants in CSAD/lnc-ITGB7-1 on Chromosome 12q13.13 Associated with Susceptibility to Fulminant Type 1 Diabetes. 2019 Mar;68(3):665-675. 

  • 2019
  • Nishimoto M, Ohtsu H, Marumo T, Kawarazaki W, Ayuzawa N, Ueda K, Hirohama D, Kawakami-Mori F, Shibata S, Nagase M, Isshiki M, Oba S, Shimosawa T, Fujita T. Mineralocorticoid receptor blockade suppresses dietary salt-induced ACEI/ARB-resistant albuminuria in non-diabetic hypertension: a sub-analysis of evaluate study. Hypertens Res. 2019 Apr;42(4):514-521.

  • 2019
  • Takita M, Jimbo E, Fukui T, Aida K, Shimada A, Oikawa Y, Yagihashi S, Miura J, Babazono T, Kobayashi T. Unique Inflammatory Changes in Exocrine and Endocrine Pancreas in Enterovirus-induced Fulminant Type 1 Diabetes. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4282-429.

  • 2019
  • Baden MY, Imagawa A, Abiru N, Awata T, Ikegami H, Uchigata Y, Oikawa Y, Osawa H, Kajio H, Kawasaki E, Kawabata Y, Kozawa J, Shimada A, Takahashi K, Tanaka S, Chujo D, Fukui T, Miura J, Yasuda K, Yasuda H, Kobayashi T, Hanafusa T; consultation of the Japan Diabetes Society Committee on Type 1 Diabetes Mellitus Research. Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy. Diabetol Int. 2019 Jan;10(1):58-66.

  • 2018
  • Mizutani G, Hikima Y, Satomura A, Iuchi T, Nakajima R, Miyashita Y, Yasuda S, Oikawa Y, Isshiki M, Inoue I, Noda M, Shimada A: Administration of thiamazole for Graves’ disease might trigger the onset of type  1 diabetes. J Diabetes Investig 9:1228-1229,2018

  • 2018
  • Sakai G, Saito D, Nakajima R, Hatano M, Noguchi Y, Kurihara S, Katayama S, Inoue I, Noda M, Shimada A: Intrinsic insulin secretion capacity might be preserved by discontinuing anti-programmed cell death protein 1 antibody treatment in ‘anti-programmed cell death protein 1 antibody-induced’ fulminant type 1 diabetes. J Diabetes Investig 9:448-449,2018

  • 2018
  • Shimada A, Hanafusa T, Yasui A, Lee G, Taneda Y, Sarashina A, Shiki K, George J, Soleymanlou N, Marquard J: Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4-week, double-blind, randomized, placebo-controlled phase 2 trial. Diabetes Obes Metab 20:2190-2199,2018

  • 2018
  • Ikegami Y, Inoue I, Inoue K, Shinoda Y, Iida S, Goto S, Nakano T, Shimada A, Noda M: The annual rate of coronary artery calcification with combination therapy with a  PCSK9 inhibitor and a statin is lower than that with statin monotherapy. NPJ Aging Mech Dis 4:7,2018

  • 2018
  • Ito D, Inoue K, Sumita T, Hamaguchi K, Kaneko K, Yanagisawa M, Inukai K, Inoue I, Noda M, Shimada A: Long-Term Effects of Ipragliflozin on Diabetic Nephropathy and Blood Pressure in  Patients With Type 2 Diabetes: 104-Week Follow-up of an Open-Label Study. J Clin Med Res 10:679-687, 2018

  • 2018
  • Nishimoto M, Mizuno R, Fujita T, Isshiki M: Stromal interaction molecule 1 modulates blood pressure via NO production in vascular endothelial cells. Hypertens Res 41:506-514,2018

  • 2018
  • Kondo Y, Goto A, Noma H, Iso H, Hayashi K, Noda M: Effects of Coffee and Tea Consumption on Glucose Metabolism: A Systematic Review  and Network Meta-Analysis. Nutrients 11: pii: E48, 2018

  • 2018
  • Tokunaga A, Imagawa A, Nishio H, Hayata S, Shimomura I, Abiru N, Awata T, Ikegami H, Uchigata Y, Oikawa Y, Osawa H, Kajio H, Kawasaki E, Kawabata Y, Kozawa J, Shimada A, Takahashi K, Tanaka S, Chujo D, Fukui T, Miura J, Yasuda K, Yasuda H, Kobayashi T, Hanafusa T: Diffusion-weighted magnetic resonance imaging in the pancreas of fulminant type 1 diabetes. Diabetol Int 9:257-265,2018

  • 2018
  • Kanozawa K, Noguchi Y, Sugahara S, Nakamura S, Yamamoto H, Kaneko K, Kono R, Sato S, Ogawa T, Hasegawa H, Katayama S. The renoprotective effect and safety of a DPP-4 inhibitor, sitagliptin, at a small dose in type 2 diabetic patients with a renal dysfunction when changed from other DPP-4 inhibitors: REAL trial. Clin Exp Nephrol. 2018 Aug;22(4):825-834.

  • 2018
  • Uchida J, Oikawa Y, Katsuki T, Takeda H, Shimada A, Kawai T: Insulin degludec overdose may lead to long-lasting hypoglycaemia through its markedly prolonged half-life. Diabet Med 35:277-280,2018

  • 2018
  • Katayama S, Hatano M, Issiki M. Clinical features and therapeutic perspectives on hypertension in diabetics. Hypertens Res. 2018;41(4):213-229.

  • 2018
  • Baden MY, Imagawa A, Abiru N, Awata T, Ikegami H, Uchigata Y, Oikawa Y, Osawa H, Kajio H, Kawasaki E, Kawabata Y, Kozawa J, Shimada A, Takahashi K, Tanaka S, Chujo D, Fukui T, Miura J, Yasuda K, Yasuda H, Kobayashi T, Hanafusa T; consultation of the Japan Diabetes Society Committee on Type 1 Diabetes Mellitus Research. Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy. Diabetol Int. 2018 Jul 3;10(1):58-66. 

ACCESSご案内

埼玉医科大学

埼玉医科大学病院

〒350-0495 埼玉県入間郡毛呂山町毛呂本郷38
TEL: 049-276-1204
FAX: 049-294-9752

お車をご利用される方
鶴ヶ島インターから約10km(約20~30分)
詳しくはこちら

電車・バスをご利用される方
池袋駅より東毛呂駅まで約1時間
東毛呂駅からバス(約5分)もしくは徒歩(約20分)
詳しくはこちら

本フォームは医療従事者専用となっております。ご病状やお薬、検査、予約など診療に関する患者さんからのご相談は、法律上、一切お受けすることができません。ご理解のほどよろしくお願いいたします。